Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06780176 · ClinicalTrials.gov registry record
A Study of Breast Cancer Risk Factors and Outcomes of People in Florida
A clinical trial of Breast Cancer and Breast Neoplasms, sponsored by Memorial Sloan Kettering Cancer Center.
- Recruiting
- Registry status
- 800
- Enrollment target
- 3
- Study locations
NCT06780176: Recruiting study of Breast Cancer and Breast Neoplasms, sponsored by Memorial Sloan Kettering Cancer Center.
NCT06780176 is a study of Breast Cancer and Breast Neoplasms that is actively recruiting participants, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 800 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower). The trial reports 3 study locations across 3 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06780176, a study of Breast Cancer and Breast Neoplasms, is actively recruiting participants, sponsored by Memorial Sloan Kettering Cancer Center.
- RECRUITING
- Registry status
- 800 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer.
Primary Outcome
The purpose of this study is to prospectively collect and store clinical data, blood and tissue samples, and participant survey data to evaluate (epi) genomic and non-genomic causes of disparity.
Conditions Studied
Interventions
- OTHER Biospecimen Collection
- DIAGNOSTIC_TEST Surgical Tissue Collection
- BEHAVIORAL Survey Collection
Study Locations (3)
California
- University of California, Los Angeles (Specimen Analysis only) - Los Angeles
Florida
- University of Miami (Data Collection Only) - Miami
New York
- Memorial Sloan Kettering Cancer Center (All protocol activites) - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 800 participants |
| Start Date | 2025-01-13 |
| Est. Completion | 2030-01-13 |
What NCT06780176 shows while recruiting
NCT06780176 is an observational study that tracks outcomes without assigning an intervention. The registered 800 participants enrollment target is mid-sized for trials with a published cap, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (71% lower).
The record links to 3 conditions, with Breast Cancer appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT06780176 reports a single indexed study location in California, Florida, New York.
Frequently Asked Questions
What is clinical trial NCT06780176 about?
NCT06780176 is a clinical study titled "A Study of Breast Cancer Risk Factors and Outcomes of People in Florida". The purpose of this study is to understand why different people have different risks and outcomes for breast cancer and non-breast cancer.
What is the current status of trial NCT06780176?
This trial is currently recruiting. The enrollment target is 800 participants. The study started on 2025-01-13. Estimated completion is 2030-01-13.
What conditions does trial NCT06780176 study?
This clinical trial studies the following conditions: Breast Cancer, Breast Neoplasms, Breast Diseases.
What interventions are being tested in trial NCT06780176?
The interventions under investigation include: Biospecimen Collection (OTHER), Surgical Tissue Collection (DIAGNOSTIC_TEST), Survey Collection (BEHAVIORAL).
Who is sponsoring clinical trial NCT06780176?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06780176 being conducted?
This trial has 3 study locations across California, Florida, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breast Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06780176's enrollment target sits among peer trials
800 144th of 1224 higher than 1,079 of 1,224 other Breast Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breast Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Collection of Blood From Patients With Cancer, Other Tumors, or Tumor Predisposition Syndromes for Genetic Analysis
RECRUITING
-
Surviving Daily Life
RECRUITING
-
Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring
RECRUITING
-
UNC Pleural Fluid Registry
RECRUITING
-
Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCA
RECRUITING · NA
-
Post-operative Radiotherapy Omission in Selected Patients With Early Breast Cancer Trial International VErsion (PROSPECTIVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00695214 · 800 participants · Phase 2
Drug-Induced Sleep Endoscopy for Upper Airway Evaluation in Obstructive Sleep Apnea
- NCT03048201 · 800 participants · NA
Physica System Total Knee Replacement Registry Study
- NCT03792659 · 800 participants
The EXPLORE MG Registry for Myasthenia Gravis
- NCT03819296 · 800 participants · Phase 1
Role of Gut Microbiome and Fecal Transplant on Medication-Induced GI Complications in Patients With Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI